Cargando…

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer

Background: Currently, the diagnosis of non-organ-confined bladder cancer (NOCBCa) has a very poor prognosis. For patients with NOCBCa, treatments such as radical cystectomy (RC) and systemic chemotherapy have shown survival benefits. However, the relative survival benefits of trimodal therapy (TMT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yadong, Jie, Xiaoliang, Zhang, Aihong, Zhang, Wentao, Wang, Ruiliang, Zhang, Junfeng, Mao, Shiyu, Wu, Yuan, Wang, Longsheng, Zhang, Ziwei, Yan, Yang, Wang, Ping, Yao, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909817/ https://www.ncbi.nlm.nih.gov/pubmed/31867271 http://dx.doi.org/10.3389/fonc.2019.01315

Ejemplares similares

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2019)

Corrigendum: MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1
por: Zhang, Wentao, et al.
Publicado: (2023)

Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2018)

Prognostic Significance of Young Age and Non-Bone Metastasis at Diagnosis in Patients with Metastatic Prostate Cancer: a SEER Population-Based Data Analysis
por: Guo, Yadong, et al.
Publicado: (2019)

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report
por: Mao, Shiyu, et al.
Publicado: (2019)

Effects of Radiotherapy or Radical Prostatectomy on the Risk of Long-Term Heart-Specific Death in Patients With Prostate Cancer
por: Guo, Yadong, et al.
Publicado: (2020)

MicroRNA-154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7
por: Zhang, Junfeng, et al.
Publicado: (2019)

Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study
por: Guo, Yadong, et al.
Publicado: (2018)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer
por: Turgeon, Guy-Anne, et al.
Publicado: (2014)

Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study
por: Mao, Shiyu, et al.
Publicado: (2020)

Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients
por: Yang, Fuhan, et al.
Publicado: (2021)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Depletion of CDC5L inhibits bladder cancer tumorigenesis
por: Zhang, Ziwei, et al.
Publicado: (2020)

Depletion of CDC5L inhibits bladder cancer tumorigenesis: Erratum
por: Zhang, Ziwei, et al.
Publicado: (2022)

Suppressed OGT expression inhibits cell proliferation and modulates EGFR expression in renal cell carcinoma
por: Wang, Longsheng, et al.
Publicado: (2019)

Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer
por: Wang, Longsheng, et al.
Publicado: (2018)

Prognostic significance of red cell distribution width in bladder cancer
por: Ma, Wenchao, et al.
Publicado: (2020)

Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway
por: Mao, Shiyu, et al.
Publicado: (2020)

Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis
por: Ding, Hui, et al.
Publicado: (2020)

The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a Novel Significant Prognostic Factor for Patients with Metastatic Prostate Cancer Undergoing Cytoreductive Radical Prostatectomy
por: Guo, Yadong, et al.
Publicado: (2019)

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2023)

Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis
por: Guo, Yadong, et al.
Publicado: (2022)

Bladder cancer-associated microbiota: Recent advances and future perspectives
por: Zhang, Wentao, et al.
Publicado: (2023)

Conditional survival of trimodal therapy for nonmetastatic muscle‐invasive bladder cancer: A SEER database analysis
por: Shangguan, Wentai, et al.
Publicado: (2022)

Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer
por: Guo, Yadong, et al.
Publicado: (2022)

A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Causes of Death after Prostate Cancer Diagnosis: A Population-Based Study
por: Guo, Yadong, et al.
Publicado: (2022)

Dysregulation of tumor microenvironment promotes malignant progression and predicts risk of metastasis in bladder cancer
por: Liu, Ji, et al.
Publicado: (2021)

Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
por: Zhang, Wentao, et al.
Publicado: (2022)

Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma
por: Goense, Lucas, et al.
Publicado: (2018)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Can Smoking Cause Differences in Urine Microbiome in Male Patients With Bladder Cancer? A Retrospective Study
por: Ma, Wenchao, et al.
Publicado: (2021)

SULF2 is a novel diagnostic and prognostic marker for high-grade bladder cancer with lymphatic metastasis
por: Huang, Jianhua, et al.
Publicado: (2021)

Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis
por: Su, Xiaozhe, et al.
Publicado: (2023)

Trimodal Therapy Using an MR–guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer
por: Liveringhouse, Casey, et al.
Publicado: (2023)

Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes
por: Shahbaz, Muhammad, et al.
Publicado: (2020)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review
por: Decazes, Pierre, et al.
Publicado: (2021)

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o2uv77r713pnhmjca86g4ahtp0